Fossella FV - Search Results

1

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

Cascone T, William WN Jr, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G Jr, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Cascone T, et al. Among authors: fossella fv. Nat Med. 2021 Mar;27(3):504-514. doi: 10.1038/s41591-020-01224-2. Epub 2021 Feb 18. Nat Med. 2021. PMID: 33603241 Free PMC article. Clinical Trial.

2

Systemic treatment of non-small-cell lung cancer.

Lenzi R, Fossella FV, Lee JS. Lenzi R, et al. Among authors: fossella fv. Compr Ther. 1992 Mar;18(3):27-30. Compr Ther. 1992. PMID: 1315236 Review. No abstract available.

3

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.

Shin DM, Dhingra HM, Lee JS, Fossella FV, Murphy WK, Hong WK. Shin DM, et al. Among authors: fossella fv. Am J Clin Oncol. 1992 Jun;15(3):194-9. doi: 10.1097/00000421-199206000-00003. Am J Clin Oncol. 1992. PMID: 1317094 Clinical Trial.

4

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: fossella fv. J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039. J Natl Cancer Inst. 1992. PMID: 1318977 Clinical Trial. No abstract available.

5

Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma.

Fossella FV, Winn RJ, Holoye PY, Hallinan B, Raber MN, Hoelzer K, Young JA, Readling J, Bowers B, Hong WK. Fossella FV, et al. Invest New Drugs. 1992 Nov;10(4):331-5. doi: 10.1007/BF00944191. Invest New Drugs. 1992. PMID: 1336771 Clinical Trial.

6

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: fossella fv. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

7

Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma.

Fossella FV, Winn RJ, Holoye PY, Raber MN, Holden L, Belt R, Allen H, Hallinan B, Harper K. Fossella FV, et al. Invest New Drugs. 1991 Nov;9(4):375-6. doi: 10.1007/BF00183586. Invest New Drugs. 1991. PMID: 1666631 Clinical Trial. No abstract available.

8

Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma.

Ellerbroek NA, Fossella FV, Rich TA, Ajani JA, Komaki R, Roth JA, Holoye PY. Ellerbroek NA, et al. Among authors: fossella fv. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):351-5. doi: 10.1016/0360-3016(91)90119-o. Int J Radiat Oncol Biol Phys. 1991. PMID: 1846848 Clinical Trial.

9

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

Fossella FV, Lee JS, Berille J, Hong WK. Fossella FV, et al. Semin Oncol. 1995 Apr;22(2 Suppl 4):22-9. Semin Oncol. 1995. PMID: 7740327 Review.

10

Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.

Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ, et al. Komaki R, et al. Among authors: fossella fv. Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):807-11. doi: 10.1016/0360-3016(94)00463-3. Int J Radiat Oncol Biol Phys. 1995. PMID: 7860392 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page